Medexus Pharmaceuticals Inc
TSX:MDP
Wall Street
Price Targets
MDP Price Targets Summary
Medexus Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
MDP
is 6.32 CAD
with a low forecast of 3.48 CAD and a high forecast of 8.4 CAD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MDP's stock price target?
Price Target
6.32
CAD
According to Wall Street analysts, the average 1-year price target for
MDP
is 6.32 CAD
with a low forecast of 3.48 CAD and a high forecast of 8.4 CAD.
What is Medexus Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
8%
For the last 12 years the
compound annual growth rate for
Medexus Pharmaceuticals Inc's revenue is
37%.
The projected
CAGR
for the next 3 years is
8%.
What is Medexus Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
24%
The
compound annual growth rate
of Medexus Pharmaceuticals Inc's operating income for the next 3 years is
24%.
What is Medexus Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
86%
The
compound annual growth rate
of Medexus Pharmaceuticals Inc's net income for the next 3 years is
86%.
